Multicentre validation of IMRT pre-treatment verification: Comparison of in-house and external audit

被引:27
|
作者
Jornet, Nuria [1 ]
Carrasco, Pablo [1 ]
Beltran, Merce [2 ]
Francisco Calvo, Juan [3 ]
Escude, Lluis [4 ]
Hernandez, Victor [5 ]
Quera, Jaume [6 ]
Saez, Jordi [2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Radiofis & Radioproteccio, Barcelona, Spain
[2] Hosp Vall dHebro, Serv Fis, Barcelona, Spain
[3] Hosp Quiron, Serv Oncol Radioterap, Barcelona, Spain
[4] Clin Teknon, Serv Oncol Radioterap, Barcelona, Spain
[5] Hosp St Joan, Serv Fis, Reus, Spain
[6] Hosp Esperanza, Serv Oncol Radioterap, Barcelona, Spain
关键词
IMRT; Audit; Quality assurance; MODULATED RADIATION-THERAPY; RADIOCHROMIC FILM DOSIMETRY; QUALITY-ASSURANCE; EBT2; FILM; RADIOTHERAPY; COMPLEXITY; INDEX; QA;
D O I
10.1016/j.radonc.2014.06.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: We performed a multicentre intercomparison of IMRT optimisation and dose planning and IMRT pre-treatment verification methods and results. The aims were to check consistency between dose plans and to validate whether in-house pre-treatment verification results agreed with those of an external audit. Materials and methods: Participating centres used two mock cases (prostate and head and neck) for the intercomparison and audit. Compliance to dosimetric goals and total number of MU per plan were collected. A simple quality index to compare the different plans was proposed. We compared gamma index pass rates using the centre's equipment and methodology to those of an external audit. Results: While for the prostate case, all centres fulfilled the dosimetric goals and plan quality was homogeneous, that was not the case for the head and neck case. The number of MU did not correlate with the plan quality index. Pre-treatment verifications results of the external audit did not agree with those of the in-house measurements for two centres: being within tolerance for in-house measurements and unacceptable for the audit or the other way round. Conclusions: Although all plans fulfilled dosimetric constraints, plan quality is highly dependent on the planner expertise. External audits are an excellent tool to detect errors in IMRT implementation and cannot be replaced by intercomparison using results obtained by centres. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 50 条
  • [31] CHARACTERISATION OF THE MAPCHECK 2 FOR PRE-TREATMENT IMRT QA
    Winter, H.
    Natarajan, T.
    Belton, R.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S508 - S508
  • [32] Audit to analyse the role of pre-treatment verification in 3D CT planning for NSCLC
    Raj, S.
    Gilligan, D.
    Harden, S. V.
    LUNG CANCER, 2007, 57 : S8 - S8
  • [33] IMRT pre-treatment verification with ionization chamber, film and EPID: Quality vs. time consumption
    Starmans, M
    Dekker, A
    Nijsten, S
    Minken, A
    Lambin, P
    MEDICAL PHYSICS, 2005, 32 (06) : 1984 - 1984
  • [34] Verification of MLC Motion Error During IMRT/VMAT Delivery by Using An In-House Program
    Ehara, I.
    Hayashi, N.
    Adachi, Y.
    Yada, R.
    Matsunaga, T.
    Kato, H.
    MEDICAL PHYSICS, 2012, 39 (06) : 3788 - 3788
  • [35] Establish In-House: A Pre-Treatment Method of Fat, Oil and Grease (FOG) in Kitchen Wastewater for Safe Disposal
    Al-Gheethi, Adel
    Mohamed, Radin Maya Saphira Radin
    Nyokiew, Welfrad
    Noman, Efaq
    Kassim, Amir Hashim Mohd
    INTERNATIONAL JOURNAL OF INTEGRATED ENGINEERING, 2019, 11 (02): : 171 - 177
  • [36] Evaluation of pre-treatment verification for hyperthermia treatment plans
    Marder, D.
    Brandli, N.
    VanStam, G.
    Lutters, G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S919 - S920
  • [37] Imaging for Planning Verification: In Room Imaging: Pre-Treatment Verification
    Papanikolaou, N.
    MEDICAL PHYSICS, 2008, 35 (06) : 2926 - +
  • [38] IN VIVO DOSIMETRY AS SUBSTITUTE FOR PRE-TREATMENT VERIFICATION
    Mijnheer, B.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S191 - S191
  • [39] External validation a pre-treatment nomogram for prediction of renal cancer-specific mortality
    Jeldres, C.
    Suardi, N.
    Petard, J. J.
    Ficarra, V.
    Cindolo, L.
    De la Taille, A.
    Salomon, L.
    Tostain, J.
    Mulders, P. F.
    Zigeuner, R.
    Prayer-Galetti, T.
    Chautard, D.
    Valeri, A.
    Lechevallier, E.
    Descotes, J.
    Lang, H.
    Avakian, R.
    Bensaleh, K.
    Mejean, A.
    Bertini, R.
    Montorsi, F.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 282 - 282
  • [40] Portal Dosimetry for pre-treatment IMRT QA: Commissioning of the image system and validation against a diode array
    Martinez-Rodriguez, D.
    Candela-Rodriguez, F.
    Garcia-Martinez, T.
    Camara-Turbi, A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S859 - S859